Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Haleos Labs Business Update

USFDA inspected the material subsidiary Mahi Drugs' API facility in Parawada. The inspection concluded with zero Form 483 observations.

Source

BSE filing, NSE: HALEOSLABS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Haleos Labs Ltd: key numbers

Share price
₹1,450.60
Market cap
₹438.6 Cr
Revenue (annual)
₹333.8 Cr
Net profit (annual)
₹17.31 Cr
P/E (TTM)
27.8×Sector 46.1×
Promoter holding
72.11%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Haleos Labs Ltd

All →

Other business update announcements

All →